Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
暂无分享,去创建一个
L. Moreno | J. L. Izquierdo-García | M. Callejo | I. Rodríguez | Palmira Villa-Valverde | Á. Cogolludo | Sergio Esquivel-Ruiz | R. Pandolfi | J. Ruiz-Cabello | Daniel Morales-Cano | Bianca Barreira | Sergio Esquivel-Ruiz | Rachele Pandolfi | Palmira Villa-Valverde | Angel Cogolludo | Francisco Perez-Vizcaino | F. Pérez-Vizcaino | Bianca Barreira | Daniel Morales-Cano